Note: Perhaps you missed this bit of swamp draining on the evening news earlier this month. Despite President Trump's lack of progress regarding vaccination safety or choice, he has made some inroads when it comes to Big Pharma. Drugs over $35 per month will have to share their costs in direct to consumer ads. "Ask your Doctor if this drug costs more than your monthly mortgage...." Transparency is part of informed consent. Wouldn't it be nice if we had some in the vaccination arena - or should I say the Coliseum, where our rights are the Christians and Pharma and Public health are the lions. Keep the faith, friends.
Excerpted from Cortical Chauvinism a site discussing autism issues, by Dr. Manuel Casanova. We invite you to bookmark the site:
From Medical News (Physicians First Watch) published May 10, 2019
Direct-to-consumer television ads for prescription drugs covered by Medicare or Medicaid will have to disclose the list price if it’s $35 or more for a month’s supply (or the usual course of treatment), the U.S. Department of Health and Human Services said on Wednesday.
HHS noted that the 10 most frequently advertised drugs cost between $480 and $17,000.
The rule is expected to go into effect within 60 days.
Separately, the Trump administration on Thursday said it wants to reduce surprise medical billing. Here are two of the proposals the administration put forth: In emergencies, patients shouldn’t be billed above the amount they’re allowed in-network, even if they receive care outside their network. Patients should also be given information before receiving care about whether the providers are in their insurance network and how much out-of-network care could cost.
Dr. Manuel Casanova is a neurologist, with extensive experience in Neuropathology and research. He is currently the SmartState Chair in Childhood Neurotherapeutics and Professor of Biomedical Sciences at the University of South Carolina/Greenville Health Systems.